| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Klinik und Poliklinik für Neurologie (Drs. Stögbauer, Young, and Kuhlenbäumer), Westfälische Wilhelms Universität, Münster, Germany; Flanders Interuniversity Institute for Biotechnology, Born Bunge Foundation (Drs. Kuhlenbäumer, De Jonghe, and Timmerman), University of Antwerp, Department of Biochemistry; and the Division of Neurology (Dr. De Jonghe), University Hospital Antwerpen, Antwerp, Belgium.
Address correspondence and reprint requests to Dr. Florian Stögbauer, Klinik und Poliklinik für Neurologie, Westfälische Wilhelms Universität Münster, Albert Schweitzer Str. 33, D-48129 Münster, Germany; e-mail: stogbau{at}uni-muenster.de
The authors review the molecular genetics and pathophysiology of hereditary recurrent focal neuropathies: hereditary neuropathy with liability to pressure palsies (HNPP) and hereditary neuralgic amyotrophy (HNA). Significant progress in the understanding of HNPP and HNA has been achieved. HNPP and HNA are distinct clinical and pathologic disease entities with autosomal dominant inheritance. Molecular genetic studies have shown that HNPP and HNA are located on chromosome 17 but at distinct genetic loci (17p11.2 for HNPP, 17q25 for HNA). The 1.5 megabase deletion in 17p11.2 is the major cause of HNPP. This interstitial deletion causes the complete loss of one allele of the peripheral myelin protein 22 (PMP22) gene. Interestingly, rare HNPP patients are found without the 1.5 megabase deletion. However, these patients have distinct mutations in the PMP22 gene resulting in altered expression of the PMP22 protein. Current molecular genetic tests and clinical guidelines allow improved diagnosis, prognosis, and genetic counseling for patients with HNPP. Such tests are not available for HNA, because the disease-causing gene remains unknown. Molecular genetic advances in HNPP and HNA, as well as the study of transgenic animal and cellular models, will provide a more precise understanding of the disease mechanisms and will lead to the development of effective therapeutic tools for patients with inherited and sporadic recurrent peripheral neuropathies.
Key words: Hereditary neuropathy with liability to pressure palsies—Hereditary neuralgic amyotrophy—Peripheral myelin protein-22—Brachial neuritis
This article has been cited by other articles:
|
|
 |
|
  W. J. Triggs and D. Cros Case 40-2007 -- A 38-Year-Old Man with Weakness in the Hands N. Engl. J. Med., December 27, 2007; 357(26): 2707 - 2715. [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. O'Sullivan, A. McCarthy, G. M. Mullins, B. McNamara, and B. J. Sweeney ALS in a patient with hereditary neuropathy with liability to pressure palsy Neurology, December 26, 2006; 67(12): 2260 - 2260. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Peters and N. P. Hinds Inherited Neuropathy Can Cause Postpartum Foot Drop Anesth. Analg., February 1, 2005; 100(2): 547 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.J. Hardon, N. van Alfen, M.J. Zwarts, and J.J. Rotteveel Hereditary neuropathy with liability to pressure palsies in a toddler Neurology, December 24, 2002; 59(12): 2008 - 2008. [Full Text] [PDF]
|
|
|
|
|
|
I. Korn-Lubetzki, I. Steiner, K. Mori, N. Hattori, M. Yamamoto, and G. Sobue Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS Neurology, December 10, 2002; 59(11): 1823 - 1824. [Full Text] [PDF]
|
|
|
|
|
|
J. Li, K. Krajewski, M. E. Shy, and R. A. Lewis Hereditary neuropathy with liability to pressure palsy: The electrophysiology fits the name Neurology, June 25, 2002; 58(12): 1769 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ohkoshi, Y. Kohno, A. Hayashi, T. Wada, and S. Shoji Acute vocal cord paralysis in hereditary neuropathy with liability to pressure palsies Neurology, May 22, 2001; 56(10): 1415 - 1415. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
